Synaptogenix Inc. (NASDAQ: SNPX) Announce Publication of Peer-Reviewed Data of Bryostatin...
Synaptogenix Inc. (NASDAQ: SNPX) has announced a peer-reviewed scientific publication in the Journal of Alzheimer’s Disease entitled, “Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Neurotrope Inc. (NASDAQ:NTRP) Announce Commencement Of New Long Term Study Bryostatin-1...
Neurotrope Inc. (NASDAQ:NTRP) has announced the launch of a new second phase study of Bryostatin-1 for the treatment of Alzheimer's disease patients.
Neurotrope receives $2.7...
MAKE IT MODERN
LATEST REVIEWS
MannKind Corporation (NASDAQ:MNKD) Posts Revenues Of $15.1 Million In Q2 2020
MannKind Corporation (NASDAQ:MNKD) reported revenues of $7 million from the sale of Afrezza and $8.1 million from the services/ collaboration segment.
CEO of MannKind, Michael...
MAKE IT MODERN
PERFORMANCE TRAINING
Auris Medical Holding Ltd (NASDAQ: EARS) Clinches Trasir To Concentrate On RNA Therapeutics Development
Auris Medical Holding Ltd (NASDAQ: EARS) took over Trasir Therapeutics, Inc to concentrate on RNA Therapeutics development.
Inducts Samuel Wickline as CSO
The company will assume...
OncoCyte Corp (NYSEAMERICAN:OCX) and the Guardian Research Network® Collaborate to Establish an Integrated Platform...
Cancer is a leading cause of death in the United States. Victims and their families, employers, and insurance companies spend over 150 billion dollars...
Aytu Bioscience Inc (NASDAQ:AYTU) Reports An Impressive Fiscal Q4 2020 Performance
Aytu Bioscience Inc (NASDAQ:AYTU) recently released its financial report for its fiscal Q4 2020 ended June 30, 2020, revealing impressive financial highlights.
The company’s net...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Announces Q3 2021 Financial Results And Updates On Expansion...
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) has announced financial results for the quarter ending September 30, 2021, and offered a business update.
Corvus ended Q3 2021...
Penny Stocks In Focus HPCO, BREA, GNS
This weekend the news of The U.S. Department of Transportation investigating Neuralink, Elon Musk's brain-computer interface company, for allegedly unsafe packaging and...























































